JPM2024: Big Tech Poised to Disrupt Biopharma with AI-Based Drug Discovery

On Sunday, ahead of the J.P. Morgan Healthcare Conference, Alphabet’s artificial intelligence startup Isomorphic Labs secured its first pharma partnerships with Eli Lilly and Novartis worth nearly $3 billion.

Scroll to Top